REFERENCES
- Accordino, M. P., Porter, D. F., Morse, T. (2001, April/June). Deinstitutionalization of persons with severe mental illness: Context and consequences. Journal of Rehabilitation Medicine, 67(2), 16–21, Retrieved from http:// findarticles.com/p/articles/mi_m0825/is_2_67/ai_76398484/
- Agency for Healthcare Research and Quality. (2010, December). Comparative effectiveness of first-generation and second-generation antipsychotics in the adult population. Retrieved from http://effectivehealthcare.ahrq.gov/index. cfm/search-for-guides-reviews-and-reports/?productid=583&pageaction= displayproduct
- Crismon, M. L., Argo, T. R., & Buckley, P. F. (2008). Schizophrenia. In J. T. Dipiro (Ed.), Pharmacotherapy: A pathophysiologic approach (pp. 1099–1122). China: McGraw-Hill Medical, Retrieved from http:// effectivehealthcare.ahrq.gov/index.cfm/search-for-guides-reviews-and- reports/?productid=583&pageaction=displayproduct
- Geddes, J., Freemantle, N., Harrison, P., & Bebbington, P. (2000, December). Atypical antipsychotics in the treatment of schizophrenia: Systematic overview and meta-regression analysis. British Medical Journal, 321(7273), 1371–1376. Retrieved from http://bmj.com/cgi/pmidlookup?view=long& pmid=11099280
- Gever J. (2009, December 4). No reason to prefer atypical antipsychotics over older drugs. MedPage Today. Retrieved from http://www.medpagetoday. com/Psychiatry/Schizophrenia/12029
- Leucht, S., Corves, C., Arbter, D., Engel, R. R., Li, C., & Davis, J. M. (2009, January). Second-generation versus first-generation antipsychotic drugs for schizophrenia: A meta-analysis. Lancet, 373(9657), 31–41.
- Lowry, F. (2011, June 16). Older antipsychotics trump newer agents for schizophrenia. Newer not necessarily better, researchers say. Medscape Medical News, Retrieved from http://www.medscape.com/viewarticle/744755
- Masand, P. S., & Narasimhan, M. (2006). Improving adherence to antipsychotic pharmacotherapy. Current Clinical Pharmacology, 1(1), 47–56.
- National Institute of Mental Health. (2009). Schizophrenia. Retrieved from http://www.nimh.nih.gov/health/topics/schizophrenia/index.shtml
- Revisiting the CATIE schizophrenia study. Although questions remain, some clinical guidance has emerged. (2008). Harvard Mental Health Letters, 25(1), 1–3.
- Schizophrenia.com. (2010). Schizophrenia Facts and Statistics. Retrieved from http://www.schizophrenia.com/szfacts.htm
- Seeman, P. (2002, February). Atypical antipsychotics: Mechanism of action. Canadian Journal of Psychiatry, 47(1), 27–38.
- Simon, H. (Ed.). (2009, January 2). Schizophrenia treatment. University of Maryland Medical Center. Retrieved from http://www.umm.edu/patiented/ articles/what_general_guidelines_treating_schizophrenia_000047_7.htm
- Yang, S. Y., Yang, Y. H. K., Chong, M. Y., Yang, Y. H., Chang, W. H., & Lai, C. S. (2007). Risk of extrapyramidal syndrome in schizophrenic patients treated with antipsychotics: A population-based study. Clinical Pharmacology & Therapeutics, 81(4), 586–594.